The US non-profit Mayo Clinic will use blockchain technology as part of a design study involving ten research sites and more than 500 patients to include verified clinical data. The Mayo Clinic is partnering with Triall, a Dutch startup that provides a tokenized platform for blockchain-integrated clinical trials, for this project, the companies said on Thursday. To advance clinical trial design and decentralized clinical research globally, researchers from the American healthcare company are collaborating with Triall’s eClinical team. Partnership For Clinical Trial Design According to the firms, the trial is set to begin this September, and see Triall’s eClinical platform supports a multi-center pulmonary arterial hypertension trial over the next two years. The trial would include more than 500 individuals from 10 US research facilities. The blockchain startup’s eClinical solutions were expected by Mayo Clinic to cover every essential component of the trial, including data collection, study monitoring, document management, and eConsent. Triall’s Verifiable Proof API Through audit trails that take advantage of blockchain immutability, the cooperation highlights the potential for Triall’s Verifiable Proof API to improve clinical data integrity. The cooperation also aims to investigate the feasibility of a medical ecosystem system-independent interface, where researchers, investigators, regulators, and other trial stakeholders ca...
